BPC-157 is a peptide comprising 15 amino acids, derived from a naturally occurring protein found in gastric fluid. It is currently under investigation for its diverse regenerative and protective physiological effects.
BPC-157, also known as Body Protection Compound-157 or PL 14736, is a synthetic peptide based on a natural compound present in human stomach acid. This 15-amino acid sequence has garnered significant scientific interest due to its wide range of regenerative and cytoprotective properties. Research predominantly conducted in animal models indicates its potential to facilitate healing processes across various bodily systems, including the gastrointestinal tract, musculoskeletal system, and nervous system. The peptide's primary applications in research revolve around its capacity for accelerated wound healing and tissue regeneration. It has shown promise in repairing different types of tissues, such as muscles, tendons, ligaments, and bones. Beyond its regenerative attributes, BPC-157 also demonstrates protective effects on organ systems, particularly the stomach and liver, shielding them from various forms of damage and promoting recovery. Further investigations highlight BPC-157's neuroprotective capabilities and its role in maintaining gut-brain axis integrity. It is believed to contribute to improved cognitive function and mood regulation. The pro-angiogenic properties of BPC-157, which involve the stimulation of new blood vessel formation, are central to many of its therapeutic actions, enhancing oxygen and nutrient supply to injured areas. While promising, it is important to note that most of the current evidence stems from preclinical studies, with limited human data available.
BPC-157 exerts its biological effects by interacting with various physiological pathways. It stimulates the formation of new blood vessels through boosting vascular endothelial growth factor, and it counteracts the inhibitory effects of 4-hydroxynonenal on growth. The peptide also upregulates numerous growth factor receptors and enhances fibroblast production, which is crucial for collagen synthesis.
Typical daily subcutaneous administration involves a dosage ranging from 250 to 500 micrograms. A general guideline employed by researchers is 2-4 micrograms per kilogram of body weight. The peptide is usually reconstituted with bacteriostatic water for injection.
The safety profile of BPC-157 in humans is not yet well-established, as it has not undergone formal evaluation by regulatory bodies like the FDA. While preclinical studies and limited human observations suggest minimal side effects, the long-term implications and potential risks remain largely unexplored. Due to its pro-angiogenic properties, there is a theoretical concern regarding its potential impact on existing cancers, though this requires further investigation. It is crucial to handle and administer BPC-157 with caution and only within a controlled research setting.
ARA-290
A tissue-protective peptide derived from erythropoietin. Shows remarkable efficacy for neuropathy, tissue healing, and inflammation reduction without erythropoietic activity.
1.5 mgBody Protection Compound-157 and Thymosin Beta-500 Blend
A powerful healing combination that synergistically promotes tissue repair, reduces inflammation, and accelerates recovery from injuries.
250 mcg eachGHK-Cu, BPC-157, and TB-500 Blend
A healing and beauty peptide combination. GHK-Cu provides skin regeneration and collagen synthesis while BPC-157 and TB-500 accelerate tissue repair.
2.5 mg/500mcg/500mcgGHK-Cu, BPC-157, TB-500, and KPV Blend
An advanced healing and recovery blend combining tissue repair peptides with anti-inflammatory KPV for comprehensive recovery support.
2.5 mg/500mcg/500mcg/500mcg